HempFusion

About HempFusion

HempFusion Wellness Inc. operates as a health and wellness supplement company, focusing on the manufacturing, marketing, and distribution of hemp-based cannabidiol (CBD) and probiotic products. The company was co-founded in 2013 by Jason Mitchell, a naturopathic doctor, along with Ian deQueiroz and Andrew Oliver. Mitchell's journey into the natural products industry was deeply personal, influenced by his upbringing and later a diagnosis of Ulcerative Colitis, which inspired him to explore the benefits of probiotics and eventually hemp extract.

The company's business model revolves around a multi-channel distribution strategy, encompassing food, drug, and mass (FDM) retailers, e-commerce platforms, convenience stores, and healthcare professionals. Revenue is generated through both business-to-business (B2B) and direct-to-consumer (DTC) sales. Its products are available in thousands of retail locations, including major national chains like Kroger, CVS, Walgreens, and Whole Foods, as well as through its own websites and other online marketplaces like Amazon and Tmall. A significant aspect of its strategy includes a private label business, providing products for national retailers. The company became publicly traded with an initial public offering on the Toronto Stock Exchange in January 2021.

HempFusion's product portfolio is extensive, featuring tinctures, capsules, gummies, and topical products under several brands, including HempFusion CBD, Sagely Naturals, and Apothecanna. The core of its CBD products is the proprietary Whole Food Hemp Complex™, which utilizes broad-spectrum hemp extract containing CBD plus other cannabinoids and terpenes to achieve what is known as the "entourage effect." A key differentiator is the company's focus on regulatory compliance and safety. HempFusion has invested in scientific research, including toxicology studies, to achieve a self-affirmed Generally Recognized as Safe (GRAS) status for its hemp-derived CBD extract, a milestone that positions it favorably for compliance with U.S. and global standards. The company has also made strategic acquisitions, such as Sagely Naturals, a brand targeting women, and Apothecanna, which appeals to the Baby Boomer demographic, to expand its market reach and revenue. In late 2022, HempFusion completed the sale of its probiotic business, Probulin, to concentrate on its core CBD segment. However, in June 2023, the company filed for bankruptcy after ceasing operations.